DIRECT COMPARISON OF CERTOLIZUMAB PEGOL, ABATACEPT AND BIOSIMILAR INFLIXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN ROUTINE CARE. OBSERVATIONAL DATA FROM THE DANISH DANBIO REGISTRY ANALYZED LIKE A RANDOMIZED CLINICAL TRIAL

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftfagfællebedømt

OriginalsprogEngelsk
ArtikelnummerSAT0595
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind78
Udgave nummerSuppl 2
Sider (fra-til)1391-1391
ISSN0003-4967
DOI
StatusUdgivet - 2019

ID: 238533512